0
0
Home » Medical Devices » In Vitro Diagnostics

PCR Systems Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2030

The PCR systems market was valued at $1.57 billion in 2021. They are used for diagnosis and screening of a wide array of infectious diseases as well as for testing cancer patients and hereditary diseases. Nucleic acid amplification tests (NAAT) and PCR systems are frequently used to screen for cytomegalovirus (CMV), human papillomavirus (HPV), mycobacterium tuberculosis, chlamydia trachomatis, hepatitis, and human immunodeficiency virus (HIV).

The PCR Systems market model is built to visualize quantitative market trends within in vitro diagnostics therapeutic area.

PCR systems market overview

PCR systems market overview

 

For more insights on this report, download a free report sample

What are the market dynamics in the PCR systems market?

The market for PCR systems is increasing due to their reliability, advanced amplification technology, and fast testing mechanisms. In both developed and developing countries, PCR systems are installed in hospital and reference laboratory settings. Primary research participants indicate that these machines are typically purchased outright rather than being rented or leased. During the forecast period, revenue is expected to be driven primarily by automated PCR systems and dPCR systems. Additionally, point of care qPCRs also remain an increasing market.

What is the regional outlook of the PCR systems market?

The key regions in the PCR systems market are North America, Europe, Asia Pacific, South and Central America, and Middle East and Africa.

North America

North America holds the largest share of the overall PCR systems market, and sales are expected to remain strong during the forecast period. A rise in the prevalence of cancer cases, increased incidence of multiple infectious diseases, and a growing preference amongst physicians for precision medicine will drive the growth of the PCR systems market in the region.

Europe

The consolidation of small and medium laboratories into large, core facilities in most European countries is expected to drive steady growth of the PCR systems market. Moreover, increasing patient volumes and demand for molecular diagnostic services will also drive growth in all segments of the PCR systems market.

Additionally, growth is also expected to be driven in the German, Italian, UK, Norwegian, and Swedish PCR systems markets by upcoming changes in government guidelines and/or the rollout of new national screening programs for cervical cancer involving HPV nucleic acid amplification tests (NAAT).

Asia Pacific

APAC is one of the fastest-growing regions for PCR systems. Sales in this region are being driven by multiple factors including increasing adoption of molecular diagnostics, aging populations, gains in the prevalence and incidence of cancer cases, and the rising incidence of various infectious diseases. In specific markets such as China and India, concessional pricing and strong initiatives designed to combat diseases such as HIV and tuberculosis will continue to drive installations of PCR systems throughout the forecast period. 

South and Central America

Due to increasing demand, improving healthcare infrastructures, and widening distribution networks, the PCR systems market in South America is expected to grow stably during the forecast period. Although, a lack of sufficient infrastructure for precision medicine and associated approval bodies in some countries have negatively impacted the growth of this medical device market. Market access in the region is limited by a lack of hospitals in rural areas, reduced education and awareness of diseases, and a lower number of specialists and facilities that can help manage patients in primary care settings.

Middle East and Africa

Increasing investments in healthcare infrastructure and state-of-the-art medical research facilities in the Middle East and Africa are expected to enable access to PCR systems during the forecast period. Other factors driving this PCR systems market include growing populations, improvements in life expectancy, and increased awareness among both patients and physicians regarding available treatment options.

What are the key segments in the PCR systems market?

The key segments in the PCR systems market are automated qPCR systems, digital PCR systems, point of care PCR systems, and semi automated qPCR systems.

PCR systems market, by segments

PCR systems market, by segments

For more segment insights, download a free report sample

Which are the key companies in the PCR systems market?

Some of the key companies in the PCR systems market are F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Thermo Fisher Scientific Inc, Qiagen NV, Abbott Laboratories, bioMerieux Inc, Becton Dickinson and Co, Siemens AG, Cepheid Inc, Fluidigm Corp, and Hologic Inc.

PCR systems market, by key companies

PCR systems market, by key companies

To know more about key companies, download a free report sample

Market Report Scope

Market size (Year – 2021) $1.57 billion
Key regions North America, Europe, Asia Pacific, South and Central America, and Middle East and Africa
Key sub-segments Automated qPCR Systems, Digital PCR Systems, Point of Care PCR Systems, and Semi Automated qPCR Systems
Key companies F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Thermo Fisher Scientific Inc, Qiagen NV, Abbott Laboratories, bioMerieux Inc, Becton Dickinson and Co, Siemens AG, Cepheid Inc, Fluidigm Corp, and Hologic Inc

This report provides:

  • Currently marketed PCR systems and evolving competitive landscape.
  • Insightful review of the key industry trends.
  • Annualized total PCR systems market revenue by segment and market outlooks from 2015-2030.
  • Market level data on units, average selling prices, and market values.
  • Global, regional, and country-level market-specific insights.
  • Qualitative market-specific information with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
  • SWOT analysis for PCR Systems market.
  • Competitive dynamics insights and trends provided for PCR systems market.
  • Country specific overview of the healthcare system.
  • Country specific reimbursement policies.
  • Country specific medtech regulatory landscape.

Reasons to Buy

  • Understand the impact of COVID-19 on the PCR systems market.
  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving the PCR systems market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the PCR systems market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
  • Track device sales in the global and country-specific PCR systems market from 2015-2030.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.

Key Players

F. Hoffmann-La Roche Ltd

Bio-Rad Laboratories Inc

Thermo Fisher Scientific Inc

Qiagen NV

Abbott Laboratories

bioMerieux Inc

Becton Dickinson and Co

Siemens AG

Cepheid Inc

Fluidigm Corp

Hologic Inc

Others

Frequently Asked Questions

The PCR systems market was valued at $1.57 billion in 2021.

The key regions in the PCR systems market are North America, Europe, Asia Pacific, South and Central America, and Middle East and Africa.

The key segments in the PCR systems market are automated qPCR systems, digital PCR systems, point of care PCR systems, and semi automated qPCR systems.

Some of the key companies in the PCR systems market are F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Thermo Fisher Scientific Inc, Qiagen NV, Abbott Laboratories, bioMerieux Inc, Becton Dickinson and Co, Siemens AG, Cepheid Inc, Fluidigm Corp, and Hologic Inc.

    Pricing

Discounts available for multiple purchases.

reportstore@globaldata.com
+44 20 7947 2960

Join our mailing list

Saved reports